JPRN-jRCT2080222089未知3 期
Phase III Study of Z-206
适应症
试验速览
- 阶段
- 3 期
- 入组人数
- 600
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 16age old 至 <= 64age old（—）
- 性别
- All
入选标准
- •Those who are with ulcerative colitis in remission state
排除标准
- •-Those who have a history of drug hypersensitivity to mesalazine or salicylic acid series
研究者
相似试验
未知
2 期
Phase II Study of Z-206lcerative colitisJPRN-jRCT2080221898Zeria Pharmaceutical Co., Ltd.
已完成
3 期
Z-206 Phase III Clinical Trial - Investigation on the remission-inducing effect in patients with Crohn's disease in active phasePatients with Crohn's disease in active phaseJPRN-C000000300Zeria Pharmaceutical Co.,LTD60
未知
3 期
Z-206 Phase III Clinical Trial - Investigation on the remission-inducing effect in patients with Crohn's disease in active phasePatients with Crohn's disease in active phaseJPRN-jRCT2080220189Zeria Pharmaceutical Co., Ltd.
已完成
3 期
Z-206 Phase III Clinical Trial - Investigation on the remission-maintaining effect in patients with ulcerative colitis in remission phasePatients with ulcerative colitis in remission phase.JPRN-C000000289Zeria Pharmaceutical Co.,LTD.120
未知
3 期
Z-206 Phase III Clinical Trial - Investigation on the remission-inducing effect in patients with ulcerative colitis in active phasePatients with ulcerative colitis in active phaseJPRN-jRCT2080220176ZERIA Pharmaceutical Co.,Ltd.